Vitamin D-3 analogue KH1060 combined with TPA synergistically induces mature macrophages in human myeloblastic leukemia ML-1 cells

Citation
Y. Saito et al., Vitamin D-3 analogue KH1060 combined with TPA synergistically induces mature macrophages in human myeloblastic leukemia ML-1 cells, ANTICANC R, 19(2A), 1999, pp. 1069-1076
Citations number
33
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
2A
Year of publication
1999
Pages
1069 - 1076
Database
ISI
SICI code
0250-7005(199903/04)19:2A<1069:VDAKCW>2.0.ZU;2-C
Abstract
A human myeloblastic leukemia cell line, ML-1, was induced to differentiate along the monocytic lineage following exposure to a 1,25-dihydroxyvitamin D3 analogue, 20-epi-22-oxa-24a,26a,27a-tri-homo-1,25-dihydroxyvitamin D3 (K H1060) or 12-O-tetradecanoylphorbol-13-acetate (TPA). The combination of KH 1060 and TPA synergistically induced differentiation of ML-1 cells into mat ure macrophages with multinuclei. Maturation was also observed in other dif ferentiation characteristics such as phagocytic activity, a-naphthyl acetat e esterase activity, and expression of surface antigen CD14. Differentiated ML-1 cells showed attenuation of telomerase activity and cessation of prol iferating activity based on evaluation of the expression of genes related t o cell growth potential. Remarkable synergism was observed in TNF productio n. Treatment with TPA prior to KH1060 resulted in only slight production gf TNF; however, treatment with KH1060 preceding TPA induced a substantial am ount of TNF.